Prosecution Insights
Last updated: October 02, 2026

Examiner: ABOUELELA, MAY A

Tech Center 3700 • Art Units: 3645 3687 3736 3791 3796

This examiner grants 75% of resolved cases

Analysis

May A. Abouelela has experience in Tech Center 3700, having overseen 770 resolved cases. The 75.2% allowance rate in Art Unit 3645 indicates the frequency of grants. This metric shows the outcome for applications reaching a final resolution. The interview lift of 36.3% highlights the impact of personal engagement during the examination process.

Conducting an interview appears to provide a boost to the probability of success. Practitioners can use this data to plan the prosecution of an application. The median days to allowance is 1150. This timeline provides an expectation for the duration of the patent lifecycle from filing to grant.

The 770 resolved cases provide a basis for these metrics. The 36.3% interview lift and 1150-day median are key factors for applicants to consider when developing their strategy. The 75.2% allowance rate remains a primary indicator of success.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.3%
Allow Rate
+5.3% vs TC avg
798
Total Applications
+36.1%
Interview Lift
1149
Avg Prosecution Days
Based on 772 resolved cases, 2023–2026

Rejection Statute Breakdown

10.5%
§101 Eligibility
18.2%
§102 Novelty
33.9%
§103 Obviousness
28.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18275802 GUIDEWIRES AND METHODS OF DEPLOYMENT THEREOF Final Rejection Covidien LP
18287421 INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND COMPUTER-READABLE MEDIUM Final Rejection NEC Corporation
18954214 DISPLAY OF COMPLEX AND CONFLICTING INTERRELATED DATA STREAMS Non-Final OA Cilag GmbH International
18854119 SYSTEM FOR PERFORMING A SOUND-BASED SENSING OF A SUBJECT IN A SENSING AREA Non-Final OA SIGNIFY HOLDING B.V.
18595628 OCULAR DERIVED BLOOD FLOW AND OXYGENATION VIA EYE TRACKING Final Rejection Rockwell Collins, Inc.
18598309 BIOLOGICAL INFORMATION ACQUISITION DEVICE Non-Final OA Murata Manufacturing Co., Ltd.
17595384 SYSTEM AND METHOD FOR CLOSED LOOP CONTROL OF AUTONOMIC FUNCTION Final Rejection REGENTS OF THE UNIVERSITY OF MINNESOTA
18817871 MEDICAL DEVICES WITH AN OPTICAL MODULE Non-Final OA Cardiac Pacemakers, Inc.
18597748 SYSTEM AND METHOD FOR DETECTING AN EMOTIONAL STATE Non-Final OA Northwestern University
18835592 BALANCE SYSTEM DEVELOPMENT TRACKING Final Rejection Cochlear Limited
18695144 DAILY FASTING METHANE TO DETECT INTESTINAL METHANOGEN OVERGROWTH AND MONITOR TREATMENT RESPONSE Non-Final OA Cedars-Sinai Medical Center
18571009 SYSTEMS AND METHODS FOR BLOOD PRESSURE DEVICE CALIBRATION Final Rejection BaroPace, Inc.
18548875 SYSTEM AND METHOD FOR ASSESSMENT OF STROKE PATIENTS AND PERSONALIZED REHABILITATION Non-Final OA University of Pittsburgh - Of the Commonwealth System of Higher Education
18846649 A PHOTOPLETHYSMOGRAPY SENSOR HAVING A NOVEL ARRANGEMENT Non-Final OA WELL BEING DIGITAL LIMITED
18808410 METHOD, DEVICE, AND RECORDING MEDIUM FOR ESTIMATING EXERCISE FUNCTION INDEX VALUE VARIATION, AND METHOD, DEVICE, AND RECORDING MEDIUM FOR GENERATING EXERCISE FUNCTION INDEX VALUE VARIATION ESTIMATION MODEL Non-Final OA POLARIS INC.
18800375 SYSTEMS AND TECHNIQUES FOR MONITORING A USER'S MEDICAL CONDITION USING PHYSIOLOGICAL SENSORS Non-Final OA Medidata Solutions, Inc.
18597513 Lancet for Use with a Dermal Patch System Non-Final OA Satio, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month